"You don't need a weather man to know which way the wind blows": understanding differences and applications in clinical practice of randomized controlled trials on unprotected left main.
作者信息
D'Ascenzo Fabrizio, De Filippo Ovidio, Bertaina Maurizio, Iannaccone Mario, Gaita Fiorenzo
机构信息
"Città della Scienza e della Salute", University of Turin, Turin, Italy.
出版信息
Ann Transl Med. 2017 Feb;5(4):77. doi: 10.21037/atm.2017.01.72.
Abstract
摘要
相似文献
1
"You don't need a weather man to know which way the wind blows": understanding differences and applications in clinical practice of randomized controlled trials on unprotected left main.
Ann Transl Med. 2017 Feb;5(4):77. doi: 10.21037/atm.2017.01.72.
2
Taking stock: assessing the present-planning the future 'you don't need a weatherman to know which way the wind blows'.
Orthod Craniofac Res. 2004 Aug;7(3):143-9. doi: 10.1111/j.1601-6343.2004.00293.x.
3
Do you need a weatherman to know which way the wind blows?
Clin Med (Lond). 2022 Jan;22(1):1. doi: 10.7861/clinmed.ed.22.1.1.
4
Knowing that you don't know: metamemory and discourse processing.
J Exp Psychol Learn Mem Cogn. 1997 Nov;23(6):1378-93. doi: 10.1037//0278-7393.23.6.1378.
5
If you don't know where you are going, you might wind up someplace else: incidental findings in recreational personal genomics.
Am J Bioeth. 2014;14(3):12-4. doi: 10.1080/15265161.2013.879946.
6
Things We Learned Along the Way: You Don't Know What You Don't Know?
AJR Am J Roentgenol. 2019 May;212(5):949. doi: 10.2214/AJR.19.21289.
7
How do you know what you don't know, if you don't know?
Oper Dent. 2003 Mar-Apr;28(2):107-8; discussion 108.
8
Education-based disparities in knowledge of novel health risks: The case of knowledge gaps in HIV risk perceptions.
Br J Health Psychol. 2018 May;23(2):420-435. doi: 10.1111/bjhp.12297. Epub 2018 Jan 31.
9
If you don't know where you're going.......you may wind up somewhere else.
J Sch Health. 1978 Nov;48(9):569.
10
Pre-Procedural Forearm DSA: 'If You Don't Know Where You Are Going, You Will Wind up Someplace Else' (Yogi Berra).
Cardiovasc Revasc Med. 2018 Dec;19(8):901-902. doi: 10.1016/j.carrev.2018.11.011.
本文引用的文献
1
Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.
Lancet. 2016 Dec 3;388(10061):2743-2752. doi: 10.1016/S0140-6736(16)32052-9. Epub 2016 Oct 31.
2
Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.
N Engl J Med. 2016 Dec 8;375(23):2223-2235. doi: 10.1056/NEJMoa1610227. Epub 2016 Oct 31.
3
Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting Stents.
Am J Cardiol. 2016 Jul 1;118(1):32-9. doi: 10.1016/j.amjcard.2016.04.007. Epub 2016 Apr 26.
4
Provisional vs. two-stent technique for unprotected left main coronary artery disease after ten years follow up: A propensity matched analysis.
Int J Cardiol. 2016 May 15;211:37-42. doi: 10.1016/j.ijcard.2016.02.136. Epub 2016 Mar 3.
5
Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Unprotected Left Main Coronary Artery Disease - 5-Year Outcome From CREDO-Kyoto PCI/CABG Registry Cohort-2 - .
Circ J. 2015;79(6):1282-9. doi: 10.1253/circj.CJ-15-0034. Epub 2015 Mar 30.
6
Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.
Circulation. 2014 Jun 10;129(23):2388-94. doi: 10.1161/CIRCULATIONAHA.113.006689. Epub 2014 Apr 3.
7
Prevalence and non-invasive predictors of left main or three-vessel coronary disease: evidence from a collaborative international meta-analysis including 22 740 patients.
Heart. 2012 Jun;98(12):914-9. doi: 10.1136/heartjnl-2011-301596.
8
5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience.
JACC Cardiovasc Interv. 2010 Jun;3(6):595-601. doi: 10.1016/j.jcin.2010.03.014.
9
Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry.
J Am Coll Cardiol. 2010 Jul 6;56(2):117-24. doi: 10.1016/j.jacc.2010.04.004. Epub 2010 May 6.
10
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.
N Engl J Med. 2009 Mar 5;360(10):961-72. doi: 10.1056/NEJMoa0804626. Epub 2009 Feb 18.
Zotero 插件